Described is a haemostatic device comprising a substrate and a surface formed on the substrate. The surface comprises at least one of micro- and nano-sized materials, the materials being partially embedded in a base, the surface substantially preventing wetting of the substrate. An embodiment of the device is carbon nano fibres embedded partially in a PDMS or PTFE base, on a substrate.

A high-strength absorbable internal fixation bone screw for a fracture. The bone screw is made of a degradable oriented polylactic acid section. A raw material for the oriented polylactic acid section is a poly(L-lactic acid). The specific optical rotation of the poly(L-lactic acid) is −155° to −160°. The section is made of the poly(L-lactic acid) through the processes of making a billet, orientation strengthening and quenching in order. The method for making the billet is plastic injection molding. The method for orientation strengthening is forging and pressing or extrusion. The section is turned, finely milled, or directly molded into the bone screw. The bone screw has high strength and a low rate of mechanical strength loss, ensures mechanical support during bone healing and sufficient healing time for an injured bone, has good biocompatibility, and can be degraded and absorbed.

A high-strength absorbable internal fixation bone screw for a fracture. The bone screw is made of a degradable oriented polylactic acid section. A raw material for the oriented polylactic acid section is a poly(L-lactic acid). The specific optical rotation of the poly(L-lactic acid) is −155° to −160°. The section is made of the poly(L-lactic acid) through the processes of making a billet, orientation strengthening and quenching in order. The method for making the billet is plastic injection molding. The method for orientation strengthening is forging and pressing or extrusion. The section is turned, finely milled, or directly molded into the bone screw. The bone screw has high strength and a low rate of mechanical strength loss, ensures mechanical support during bone healing and sufficient healing time for an injured bone, has good biocompatibility, and can be degraded and absorbed.

A method of treating a lesion in a gastrointestinal tract and an injectate system are provided. The method includes injecting a crosslinkable gel into a first tissue layer, the crosslinkable gel increasing a volume of the first tissue layer. The method also includes providing a crosslinker and resecting a portion of a first tissue layer having the increased volume away from a second tissue layer creating an exposed region in a remaining portion of the first layer and leaving a portion of the gel covering at least a portion of the exposed region. The injectate system includes a crosslinkable gel and a crosslinker where the crosslinkable gel and the crosslinker form a crosslinked gel having a compressive modulus of about 10-500 kPa.

A method of treating a lesion in a gastrointestinal tract and an injectate system are provided. The method includes injecting a crosslinkable gel into a first tissue layer, the crosslinkable gel increasing a volume of the first tissue layer. The method also includes providing a crosslinker and resecting a portion of a first tissue layer having the increased volume away from a second tissue layer creating an exposed region in a remaining portion of the first layer and leaving a portion of the gel covering at least a portion of the exposed region. The injectate system includes a crosslinkable gel and a crosslinker where the crosslinkable gel and the crosslinker form a crosslinked gel having a compressive modulus of about 10-500 kPa.

The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli and which have enhanced degradation due to the presence of a halogen component. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent.

The invention relates to an implant for covering bone defects in the jaw region, which comprises a magnesium film.

The invention relates to an implant for covering bone defects in the jaw region, which comprises a magnesium film.

The invention pertains to implantable medical devices for controlled delivery of therapeutic agents. Some devices according to the invention have a titanium reservoir, and a porous titanium oxide based membrane to control the rate of release of the therapeutic agent. The reservoir contains a formulation of the active agent, including a stabilizer for the active agent, wherein the stabilizer is provided in an extended release configuration.

Medical implants that include a containment layer surrounding, or surrounded by, a biodegradable medical device provide the benefit that pieces formed during degradation of the medical device are held within a constrained place and thus do not causes injury to a hosts.